Repligen(RGEN)

Search documents
Repligen(RGEN) - 2020 Q4 - Annual Report
2021-02-24 21:22
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-2729386 (State or other jurisdic ...
Repligen(RGEN) - 2020 Q4 - Earnings Call Transcript
2021-02-24 17:39
Repligen Corporation (NASDAQ:RGEN) Q4 2020 Earnings Conference Call February 24, 2021 8:30 AM ET Company Participants Sondra Newman - Global Head of IR Tony J. Hunt - President and CEO Jon K. Snodgres - CFO Conference Call Participants Dan Arias - Stifel Unidentified Analyst - J.P. Morgan Paul Knight - KeyBanc Capital Jacob Johnson - Stephens, Inc. Matthew Hewitt - Craig-Hallum Puneet Souda - SVB Leerink Brandon Couillard - Jefferies Inc Raghuram Selvaraju - H.C. Wainwright Operator Good day ladies and gent ...
Repligen(RGEN) - 2020 Q3 - Quarterly Report
2020-11-05 21:51
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 04-2729386 (State or Other ...
Repligen(RGEN) - 2020 Q3 - Earnings Call Transcript
2020-11-05 20:23
Repligen Corporation (NASDAQ:RGEN) Q3 2020 Earnings Conference Call November 5, 2020 8:30 AM ET Company Participants Sondra Newman - Global Head of Investor Relations Tony Hunt - President and Chief Executive Officer Jon Snodgres - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Puneet Souda - SVB Leerink John Kreger - William Blair Matt Hewitt - Craig Hallum Operator Good day, and welcome to the Repligen Corporation's Third Quarter 2020 Earnings Conference Call. My name Danielle, an ...
Repligen(RGEN) - 2020 Q2 - Earnings Call Transcript
2020-07-31 04:53
Repligen Corporation (NASDAQ:RGEN) Q2 2020 Earnings Conference Call July 30, 2020 8:30 AM ET Company Participants Sondra Newman - Global Head of Investor Relations Tony Hunt - President and Chief Executive Officer Jon Snodgres - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Financial Corp. Puneet Souda - SVB Leerink LLC Tycho Peterson - JPMorgan Chase & Co. Jacob Johnson - Stephens Inc. John Kreger - William Blair & Company Matthew Hewitt - Craig-Hallum Capital Group LLC Operator G ...
Repligen(RGEN) - 2020 Q2 - Quarterly Report
2020-07-30 22:43
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 04-2729386 (State or Other Juri ...
Repligen (RGEN) Investor Presentation - Slideshow
2020-05-28 19:25
R Investor Presentation E ES 8 8 R 108 SUAO May 2020 Safe Harbor This presentation contains forward looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties which may cause our plans to change or actual results to differ materially from those anticipated. In particular, unforeseen events outside of our control ma ...
Repligen(RGEN) - 2020 Q1 - Quarterly Report
2020-05-06 20:11
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 04-2729386 (State or Other Jur ...
Repligen(RGEN) - 2020 Q1 - Earnings Call Transcript
2020-05-06 18:15
Repligen Corporation (NASDAQ:RGEN) Q1 2020 Earnings Conference Call May 6, 2020 8:30 AM ET Company Participants Sondra Newman - Senior Director, IR Tony Hunt - CEO & President Jon Snodgres - CFO & Secretary Conference Call Participants Tycho Peterson - JPMorgan John Kreger - William Blair Dan Arias - Stifel Puneet Souda - SVB Leerink Jacob Johnson - Stephens Inc. Paul Knight - Janney, Montgomery, Scott Brandon Couillard - Jefferies Matt Hewitt - Craig-Hallum Ram Selvaraju - H.C. Wainwright Operator Good day ...
Repligen(RGEN) - 2019 Q4 - Annual Report
2020-02-26 21:40
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Securities registered pursuant to Section 12(g) of the Act: None OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact name of registrant as speci ...